"Clinical care for cancer patients, basic and population research of cancer causes, risk factors, treatments and outcomes."

During the past decade, Boston University Cancer Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 44 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston University Cancer Research Center" #1 sponsor was "SWOG Cancer Research Network" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "Radiation Therapy Oncology Group" with 12 trials sponsored, "Boston Medical Center" with 9 trials sponsored and "AIDS Malignancy Consortium" with 9 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston University Cancer Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "The Emmes Company, LLC" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "United States Department of Defense" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Boston University Cancer Research Center" are "Lung Cancer" (14 trials), "Breast Cancer" (8 trials), "Multiple Myeloma" (7 trials), "Head and Neck Cancer" (6 trials) and "Precancerous Condition" (6 trials). Many other conditions were trialed in "Boston University Cancer Research Center" in a lesser frequency.

Most popular intervention types in "Boston University Cancer Research Center" are "Drug" (40 trials), "Other" (26 trials), "Procedure" (22 trials), "Radiation" (20 trials) and "Biological" (15 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (9 trials), "filgrastim" (7 trials), "laboratory biomarker analysis" (7 trials), "cyclophosphamide" (6 trials) and "melphalan" (6 trials). Other intervention names were less common.

The vast majority of trials in "Boston University Cancer Research Center" are 52 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Boston University Cancer Research Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in Boston University Cancer Research Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Boston University Cancer Research Center, 2 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".